Revenue: The sum of all revenue fields included for a company's operating activities.
Fennec Pharmaceuticals Inc. (T.FRX) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
-21.66M |
|
-- |
|
-- |
|
-- |
|
-17.24M |
|
-- |
|
-21.66M |
|
-21.66M |
|
-21.66M |
|
-21.66M |
|
-21.66M |
|
-21.66M |
|
-17.24M |
|
-16.86M |
|
26.57M |
|
26.57M |
|
-0.81 |
|
-0.81 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
36.27M |
|
-- |
|
-- |
|
-- |
|
51.96M |
|
-15.69M |
|
-15.69M |
|
-15.69M |
|
27.03M |
|
| Cash Flow Statement Financials | |
-23.15M |
|
-- |
|
8.96M |
|
32.10M |
|
17.92M |
|
-14.18M |
|
7.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.56 |
|
-- |
|
-- |
|
1.64 |
|
-2.56 |
|
94.08% |
|
-60.09% |
|
-60.09% |
|
-58.74% |
|
-75.50% |
|
-75.50% |
|
-23.15M |
|
-- |
|
-- |
|
-- |
|
0.79 |
|
0.58 |
|
2.41 |
|
151.38 |
|
138.06% |
|
138.06% |
|
-59.73% |
|
-88.70% |
|
-0.58 |
|
-0.87 |
|
-0.87 |
|